Today U.S. Senator Josh Hawley (R-Mo.) introduced the Cap Insulin Prices Act, new legislation to reduce the price of insulin and protect families from Big Pharma.
“Insulin was discovered more than a century ago, yet too many Americans who rely on it have difficulty paying for it,” said Senator Hawley. “The price of insulin is straining household budgets – at a time when inflation is already squeezing families – which can lead to rationing, and even the need for more expensive treatments down the line. Patients and their families deserve better.”
More than half a million Missourians live with diabetes, many of whom rely on insulin to manage their chronic disease.
View the bill text here.
The Cap Insulin Prices Act would:
- Set a $25 out-of-pocket cap for a monthly supply of insulin through private health plans.
- Reduce to $25 the out-of-pocket cap for a monthly supply of insulin through Medicare.
- Prohibit health plans from using prior authorization and step-therapy to steer patients to insulin products that are not best for them.